|
1
|
Ludwig JA and Weinstein JN: Biomarkers in
cancer staging, prognosis and treatment selection. Nat Rev Cancer.
5:845–856. 2005.PubMed/NCBI View
Article : Google Scholar
|
|
2
|
Henry NL and Hayes DF: Cancer biomarkers.
Mol Oncol. 6:140–146. 2012.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Irigaray P and Belpomme D: Basic
properties and molecular mechanisms of exogenous chemical
carcinogens. Carcinogenesis. 31:135–148. 2010.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Belpomme D, Irigaray P, Hardell L, Clapp
R, Montagnier L, Epstein S and Sasco AJ: The multitude and
diversity of environmental carcinogens. Environ Res. 105:414–429.
2007.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kim A: Mitochondria in cancer energy
metabolism: Culprits or bystanders? Toxicol Res. 31:323–330.
2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lopez J and Tait SW: Mitochondrial
apoptosis: Killing cancer using the enemy within. Br J Cancer.
112:957–962. 2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Peretó J: Embden-meyerhof-parnas pathway.
In: Encyclopedia of Astrobiology. Amils R, Cernicharo Quintanilla,
J, Cleaves HJ, Irvine WM, Pinti D and Viso M (eds). Springer,
Berlin, Heidelberg, 2014.
|
|
10
|
Thornalley PJ: Pharmacology of
methylglyoxal: Formation, modification of proteins and nucleic
acids, and enzymatic detoxification-a role in pathogenesis and
antiproliferative chemotherapy. Gen Pharmacol. 27:565–573.
1996.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Belpomme D and Irigaray P: Methylglyoxal
as a marker of cancer. Patent PCT/EP2013/072459. Filed: October 25,
2013; issued October 25, 2017.
|
|
12
|
Martin F, Caignard A, Jeannin JF, Leclerc
A and Martin M: Selection by trypsin of two sublines of rat colon
cancer cells forming progressive or regressive tumors. Int J
Cancer. 32:623–627. 1983.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Chaplen FW, Fahl WE and Cameron DC:
Detection of methylglyoxal as a degradation product of DNA and
nucleic acid components treated with strong acid. Anal Biochem.
236:262–269. 1996.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Rabbani N and Thornalley PJ: Measurement
of methylglyoxal by stable isotopic dilution analysis LC-MS/MS with
corroborative prediction in physiological samples. Nat Protoc.
9:1969–1979. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Turner DP: Advanced glycation
end-products: A biological consequence of lifestyle contributing to
cancer disparity. Cancer Res. 75:1925–1929. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Schröter D and Höhn A: Role of advanced
glycation end products in carcinogenesis and their therapeutic
implications. Curr Pharm Des. 24:5245–5251. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Matsuura T, Owada K, Sano M, Saito S,
Tomita I and Ikekawa T: Studies on methylglyoxal. II. Changes of
methylglyoxal level accompanying the changes of glyoxalase I and II
activities in mice bearing L1210 leukemia and sarcoma 180. Chem
Pharm Bull. 34:2926–2930. 1986.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Antognelli C, Moretti S, Frosini R,
Puxeddu E, Sidoni A and Talesa VN: Methylglyoxal acts as a
tumor-promoting factor in anaplastic thyroid cancer. Cells.
8(E547)2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Talukdar D, Ray S, Ray M and Das S: A
brief critical overview of the biological effects of methylglyoxal
and further evaluation of a methylglyoxal-based anticancer
formulation in treating cancer patients. Drug Metabol Drug
Interact. 23:175–210. 2008.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Beisswenger PJ, Howell SK, Touchette AD,
Lal S and Szwergold BS: Metformin reduces systemic methylglyoxal
levels in type 2 diabetes. Diabetes. 48:198–202. 1999.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Lapolla A, Flamini R, Dalla Vedova A,
Senesi A, Reitano R, Fedele D, Basso E, Seraglia R and Traldi P:
Glyoxal and methylglyoxal levels in diabetic patients: Quantitative
determination by a new GC/MS method. ClinChem Lab Med.
41:1166–1173. 2003.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Ryu TY, Park J and Scherer PE:
Hyperglycemia as a risk factor for cancer progression. Diabetes
Metab J. 38:330–336. 2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Honek JF: Glyoxalase biochemistry. Biomol
Concepts. 6:401–414. 2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Zhang D, Tai LK, Wong LL, Chiu LL, Sethi
SK and Koay ES: Proteomic study reveals that proteins involved in
metabolic and detoxification pathways are highly expressed in
HER-2/neu-positive breast cancer. Mol Cell Proteomics. 4:1686–1696.
2005.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Chiavarina B, Nokin MJ, Durieux F, Bianchi
E, Turtoi A, Peulen O, Peixoto P, Irigaray P, Uchida K, Belpomme D,
et al: Triple negative tumors accumulate significantly less
methylglyoxal specific adducts than other human breast cancer
subtypes. Oncotarget. 5:5472–5482. 2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Hutschenreuther A, Bigl M, Hemdan NY,
Debebe T, Gaunitz F and Birkenmeier G: Modulation of GLO1
expression affects malignant properties of cells. Int J Mol.
17(pii: E2133)2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Antognelli C, Baldracchini F, Talesa VN,
Costantini E, Zucchi A and Mearini E: Overexpression of glyoxalase
system enzymes in human kidney tumor. Cancer J. 12:222–228.
2006.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Kalapos MP: The tandem of free radicals
and methylglyoxal. ChemBiol Interact. 171:251–271. 2008.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Dreher D and Junod AF: Role of oxygen free
radicals in cancer development. Eur J Cancer. 32A:30–38.
1996.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Inoue Y and Kimura A: Methylglyoxal and
regulation of its metabolism in microorganisms. Adv Microb Physiol.
37:177–227. 1995.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Kalapos MP: Methylglyoxal in living
organisms: Chemistry, biochemistry, toxicology and biological
implications. Toxicol Lett. 110:145–175. 1999.PubMed/NCBI View Article : Google Scholar
|
